Physiopathogénèse et Traitement des Maladies du Foie
- Research works
- 6 ▲ 1300% vs 2013–17
- Citations
- 37 5.8 per fractional work
- Top-10% rate
- 0.2% record average 16.5%
- Open access
- 82% world 28%
Not ranked overall: Physiopathogénèse et Traitement des Maladies du Foie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 5.3×. Every wedge is a field page.
Which research topics does Physiopathogénèse et Traitement des Maladies du Foie publish most on?
By volume in 2022–2025: Health, Medicine and Society, Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis and Genetic and Kidney Cyst Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health, Medicine and Society General Health Professions 0 works
- 2 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 3 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 4 Genetic and Kidney Cyst Diseases Genetics 0 works
- 5 Healthcare Systems and Practices General Health Professions 0 works
- 6 Liver Diseases and Immunity Hepatology 0 works
- 7 Pancreatic function and diabetes Surgery 0 works
- 8 Alcohol Consumption and Health Effects Pathology and Forensic Medicine 0 works
- 9 Liver physiology and pathology Hepatology 0 works
- 10 Drug Transport and Resistance Mechanisms Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Physiopathogénèse et Traitement des Maladies du Foie's research output changed?
Output in 2018–2022 was 1300% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Villejuif
- Prédicteurs moléculaires et nouvelles cibles en oncologie
- Contrôle transcriptionnel et épigénétique de l’hématopoïèse maligne
- Radiothérapie Moléculaire et Innovation Thérapeutique
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.